» Articles » PMID: 22425102

Decrease in and Management of Urolithiasis After Kidney Transplantation

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 2012 Mar 20
PMID 22425102
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Urolithiasis after kidney transplantation can involve several contributing factors and the treatment strategy is open to question. We determined the incidence and management of urolithiasis in kidney recipients.

Materials And Methods: We retrospectively reviewed a single center series of 3,000 kidney graft recipients during 32 years to identify those with urolithiasis. We analyzed data by the prevalence per decade, including perioperative procedures (preoperative assessment, anastomosis type and urinary drainage) and long-term followup (urinary stenosis, time to presentation, size, site, treatment type, renal function and survival).

Results: We identified 31 cases and noted a significant decrease in incidence from 2.1% to 0.6% during the 3 decades. Excluding 4 cases of donor in situ stones the mean time to diagnosis was 8.5 years. Surgical risk factors were ureteral obstruction in 41% of cases, infravesical obstruction in 14% and urinary-digestive anastomosis in 14%. A total of 12 cases (38%) were observed exclusively with 2 of spontaneous passage. With minor adaptations all mini-invasive procedures, including extracorporeal shock wave lithotripsy, endoscopy and percutaneous nephrolithotomy, were feasible in graft recipients. Antegrade procedures were facilitated by the ventral position of the graft. Eight patients (25%) were treated with open surgical ureteroureteral anastomosis.

Conclusions: Prevention with a perioperative Double-J® stent and early treatment of ureteral obstruction have decreased and stabilized the urolithiasis rate at around 0.6%. Careful surveillance or any currently available instrumental treatments of urinary stones can be valid options.

Citing Articles

Comprehensive Approaches to Urolithiasis in Renal Transplants: A Narrative Review.

Solano C, Corrales M, Panthier F, Doizi S, Traxer O J Clin Med. 2024; 13(14).

PMID: 39064308 PMC: 11278228. DOI: 10.3390/jcm13144268.


Management of deceased and living kidney donor with lithiasis: a multicenter retrospective study on behalf of the renal transplant group of the Spanish urological association.

Sierra A, Etcheverry B, Alvarez-Maestro M, Lopez J, Fiol M, Torrecilla C J Nephrol. 2024; 37(6):1621-1630.

PMID: 38907824 PMC: 11473626. DOI: 10.1007/s40620-024-01960-5.


Management of nephrolithiasis after kidney transplantation: a comprehensive review from the European Renal Association CKD-MBD working group.

Kanbay M, Copur S, Bakir C, Hatipoglu A, Sinha S, Haarhaus M Clin Kidney J. 2024; 17(2):sfae023.

PMID: 38410685 PMC: 10896178. DOI: 10.1093/ckj/sfae023.


Urolithiasis in Kidney Transplant Patients: A Multicenter KSER Research Series.

Shim K, Choi K, Kim W, Yang S, Kim D, Choo M Medicina (Kaunas). 2024; 60(1).

PMID: 38256393 PMC: 10819323. DOI: 10.3390/medicina60010132.


Acute renal failure after kidney transplantation due to mizoribine-induced ureteral stones.

Ding M, Zhao H, Zhu H BMC Nephrol. 2024; 25(1):5.

PMID: 38172705 PMC: 10765741. DOI: 10.1186/s12882-023-03418-5.